Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD (NCT06969573)
The Impact of Inhaled Treprostinil on Dyspnea and Exercise Intolerance in Mild COPD; a Pilot and Feasibility Trial
🩺 Plain-English Summary (8th-Grade Level)
The goal of this clinical trial is to evaluate the impact of inhaled Treprostinil on breathlessness and low exercise capacity in patients living with mild chronic obstructive pulmonary disease. Participants will be asked to: * Perform lung function and exercise tests * Have ultrasound of their heart * Have CT images of their lungs * Visit the lab on 5 different occasions (plus one visit to the CT imaging clinic) The researchers will compare the effectiveness and feasibility of inhaled Treprostinil to improve breathlessness upon exertion and exercise capacity
Who can join: Review the eligibility criteria below.
Location: Clinical Physiology Laboratory — Edmonton, Alberta
Age range: 50 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Clinical Physiology Laboratory — Edmonton, Alberta
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in COPD (Chronic Obstructive Pulmonary Disease)
- Modulating Locomotor-Respiratory Coupling Through Adaptive Exoskeleton Assistance in Patients With COPD — Omaha, Nebraska
- Development And Evaluation of An Adaptive Web-Based Intervention for COPD — Aurora, Colorado
- Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia — Durham, North Carolina
- COPD Exacerbation Follow Up — Park Ridge, Illinois
- Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD — San Francisco, California
Explore by condition: All COPD (Chronic Obstructive Pulmonary Disease) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.